CD8A and cancer: Interestingly, B3GNT5 expression negatively correlates with B cell and CD8+ T cell infiltration levels while positively correlating with immune-activating and immunosuppressive genes across pan-cancer, which supports the potential role of B3GNT5 as an immune checkpoint molecule and a focal point of the CSC-immune cell crosstalk.